Oruka Therapeutics (ORKA) Profit After Tax (QoQ) (2010 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -33.30% |
| Mar 31, 2024 | -84.48% |
| Dec 31, 2023 | 23.53% |
| Sep 30, 2023 | 3.78% |
| Jun 30, 2023 | -9.96% |
| Mar 31, 2023 | -14.65% |
| Dec 31, 2022 | 49.68% |
| Sep 30, 2022 | 25.87% |
| Jun 30, 2022 | 3.82% |
| Mar 31, 2022 | 42.35% |
| Dec 31, 2021 | -20.46% |
| Sep 30, 2021 | 2.52% |
| Jun 30, 2021 | -17.90% |
| Mar 31, 2021 | 20.00% |
| Dec 31, 2020 | -157.41% |
| Sep 30, 2020 | -52.92% |
| Jun 30, 2020 | 1.36% |
| Mar 31, 2020 | -7.67% |
| Dec 31, 2019 | -6.06% |
| Sep 30, 2019 | 19.50% |
| Jun 30, 2019 | 13.70% |
| Mar 31, 2019 | -11.75% |
| Dec 31, 2018 | 6.53% |
| Sep 30, 2018 | 24.72% |
| Jun 30, 2018 | 22.63% |
| Mar 31, 2018 | 34.83% |
| Dec 31, 2017 | 5.32% |
| Sep 30, 2017 | 19.72% |
| Jun 30, 2017 | -27.29% |
| Mar 31, 2017 | -2.21% |
| Dec 31, 2016 | 8.91% |
| Sep 30, 2016 | -19.65% |
| Jun 30, 2016 | -6.77% |
| Mar 31, 2016 | -15.12% |
| Dec 31, 2015 | -12.58% |
| Sep 30, 2015 | -3.49% |
| Jun 30, 2015 | 0.91% |
| Mar 31, 2015 | -5.09% |
| Dec 31, 2014 | -14.32% |
| Sep 30, 2014 | 5.03% |
| Jun 30, 2014 | -0.67% |
| Mar 31, 2014 | 18.91% |
| Dec 31, 2013 | -70.98% |
| Sep 30, 2013 | -43.70% |
| Jun 30, 2013 | -11.95% |
| Mar 31, 2013 | -27.50% |
| Dec 31, 2012 | 9.39% |
| Sep 30, 2012 | 19.11% |
| Jun 30, 2012 | 18.55% |
| Mar 31, 2012 | 13.68% |
| Dec 31, 2011 | 10.54% |
| Sep 30, 2011 | -719.73% |
| Jun 30, 2011 | 113.33% |
| Mar 31, 2011 | -38.31% |
| Dec 31, 2010 | 24.26% |
| Sep 30, 2010 | 7.22% |